Skip to content

Effect of intraoperative esketamine infusion on the incidence of hypoxemia during renal denervation

Effect of intraoperative esketamine infusion on the incidence of hypoxemia during renal denervation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077800
Enrollment
Unknown
Registered
2023-11-20
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Interventions

Esketamine intervention group:Esketamine maintains anesthesia
Refentanil control group:Refentanil maintains anesthesia

Sponsors

Hainan Ruijin Hospital (Boao Research Hospital) Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who are at least 18 years old at the time of participation, with ASA grade I–III and BMI of 19-27 kg/m2, who are scheduled to undergo elective renal artery sympathetic ablation under basic anesthesia without intubation

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to esketamine or remifentanil. 2. Use of drugs that affect the central nervous system. 3. Chronic pain. 4. Severe ischemic heart disease; Heart failure (ejection fraction <40%). 5. Severe respiratory disease (spirometry and/or forced expiratory volume <50%). 6. Abnormal liver and kidney function. 7. History of neuropsychiatric illness or substance abuse. 8. Unable to cooperate with the scale assessment. 9. Pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative hypoxemia;

Secondary

MeasureTime frame
OAAS score;Wake up time;Incidence of Intraoperative severe hypoxemia;Incidence of adverse events;Patient satisfaction; incidence of PONV ;Assessment of delirium in CAM;VAS score ;Two groups of drug dosage;Ramsay score;

Countries

China

Contacts

Public ContactLixiong Chen

Hainan Ruijin Hospital (Boao Research Hospital) Affiliated to Shanghai Jiao Tong University School of Medicine

clxjuly@163.com+86 136 4164 0545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026